Rising Biosciences Inc (RBII)

[DezzyDazzler11]

RBII PPS projection calculation equation: Time magazine: 'In 2016, the pharmaceutical companies that make opioid painkillers raked in $8.6 billion in sales for 336 million opioid prescriptions'
now let's calculate what RSII's Share Price will be if we capture just 1/10th of 1% of that 8.6B$ pie, with Cannophen and the FDA candidate pain relief cream. 1/10th of 1% of 8.6B$ = 8.6Million$, divide that by the outstanding share count of 471million rSII shares (according to Bloomberg terminal) you get = EPS (earnings per share) 0.018, which is coincidentally where the share price was earlier this year, just on the strength of Cannophen development in our labs.

so, 8.6Million$ (projected RBII market share valuation) / 471million RBII shares = 0.018 EPS (earnings per share)

EPS x P/E ratio of 25 = Projected Price Per Share = 45 cents


The Pain Management Therapeutics Market will surpass the opioid painkiller market 10-fold by the year 2024. So really, if RBII only captures 1/10th of 1% (0.001%) of the Pain Management Therapeautics market, which is projected to be worth 83 Billion dollars come 2024, that would bring RBII's market share valuation to roughly 83 Million $. Somewhere in the neighborhood of 1 hundred million dollars.
Hypothetical: RBII captures 1/10th of 1%, (0.001%) of the Pain Management Therapeutic market by the year 2024, 0.001% of 83,000,000,000$ Pain Management Therapeutic market is 83,000,000$.

83,000,000$ (projected RBII market share valuation) / 471 million RBII shares = 0.176 EPS (earnings per share)

EPS x P/E ratio of 25 = Projected Price Per Share = 4.40$ RBII

https://globenewswire.com/news-release/2016/09/28/875315/0/en/Pain-Management-Therapeutics-Market-to-Reach-US-83-0-Billion-by-2024-Transparency-Market-Research.html